CN118613722A - 使用全菌体的检测猪螺杆菌抗体的方法 - Google Patents
使用全菌体的检测猪螺杆菌抗体的方法 Download PDFInfo
- Publication number
- CN118613722A CN118613722A CN202380018734.XA CN202380018734A CN118613722A CN 118613722 A CN118613722 A CN 118613722A CN 202380018734 A CN202380018734 A CN 202380018734A CN 118613722 A CN118613722 A CN 118613722A
- Authority
- CN
- China
- Prior art keywords
- helicobacter
- suis
- subject
- helicobacter suis
- helicobacter pylori
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241001490623 Helicobacter suis Species 0.000 title claims abstract description 165
- 238000000034 method Methods 0.000 title claims abstract description 115
- 241000894006 Bacteria Species 0.000 title description 10
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 29
- 229940037467 helicobacter pylori Drugs 0.000 claims description 79
- 241000590002 Helicobacter pylori Species 0.000 claims description 75
- 239000000427 antigen Substances 0.000 claims description 40
- 102000036639 antigens Human genes 0.000 claims description 40
- 108091007433 antigens Proteins 0.000 claims description 40
- 238000002965 ELISA Methods 0.000 claims description 29
- 230000001580 bacterial effect Effects 0.000 claims description 25
- 208000015181 infectious disease Diseases 0.000 claims description 25
- 238000012360 testing method Methods 0.000 claims description 20
- 238000009739 binding Methods 0.000 claims description 11
- 230000027455 binding Effects 0.000 claims description 10
- 241000124008 Mammalia Species 0.000 claims description 7
- 210000004369 blood Anatomy 0.000 claims description 7
- 239000008280 blood Substances 0.000 claims description 7
- 238000003317 immunochromatography Methods 0.000 claims description 7
- 238000005259 measurement Methods 0.000 claims description 7
- 210000004027 cell Anatomy 0.000 description 54
- 210000002966 serum Anatomy 0.000 description 28
- 108090000765 processed proteins & peptides Proteins 0.000 description 25
- 239000000243 solution Substances 0.000 description 24
- 241000282414 Homo sapiens Species 0.000 description 23
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 21
- 239000000523 sample Substances 0.000 description 21
- 239000002953 phosphate buffered saline Substances 0.000 description 19
- 238000001514 detection method Methods 0.000 description 16
- 206010019375 Helicobacter infections Diseases 0.000 description 15
- 108090000623 proteins and genes Proteins 0.000 description 15
- 102000004169 proteins and genes Human genes 0.000 description 14
- 238000002835 absorbance Methods 0.000 description 13
- 229940098773 bovine serum albumin Drugs 0.000 description 13
- 241000282412 Homo Species 0.000 description 10
- 230000002496 gastric effect Effects 0.000 description 10
- 238000003018 immunoassay Methods 0.000 description 10
- 239000002245 particle Substances 0.000 description 10
- 230000035945 sensitivity Effects 0.000 description 10
- 229920001817 Agar Polymers 0.000 description 9
- 241000589989 Helicobacter Species 0.000 description 9
- 239000008272 agar Substances 0.000 description 9
- 230000000903 blocking effect Effects 0.000 description 9
- 239000001963 growth medium Substances 0.000 description 9
- 208000007882 Gastritis Diseases 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- 241000282887 Suidae Species 0.000 description 8
- 238000001574 biopsy Methods 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 7
- 239000012153 distilled water Substances 0.000 description 7
- 102000004196 processed proteins & peptides Human genes 0.000 description 7
- 239000013589 supplement Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 6
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 6
- 239000012091 fetal bovine serum Substances 0.000 description 6
- 239000004816 latex Substances 0.000 description 6
- 229920000126 latex Polymers 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- 239000007790 solid phase Substances 0.000 description 6
- 241000282693 Cercopithecidae Species 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 208000012895 Gastric disease Diseases 0.000 description 5
- 230000004520 agglutination Effects 0.000 description 5
- 238000003745 diagnosis Methods 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 241000282898 Sus scrofa Species 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- 125000000539 amino acid group Chemical group 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 239000004202 carbamide Substances 0.000 description 4
- 229910002091 carbon monoxide Inorganic materials 0.000 description 4
- 239000006285 cell suspension Substances 0.000 description 4
- 239000003085 diluting agent Substances 0.000 description 4
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 4
- 238000002731 protein assay Methods 0.000 description 4
- 238000003127 radioimmunoassay Methods 0.000 description 4
- 238000000527 sonication Methods 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- APKFDSVGJQXUKY-KKGHZKTASA-N Amphotericin-B Natural products O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-KKGHZKTASA-N 0.000 description 3
- 241000589876 Campylobacter Species 0.000 description 3
- 241000283707 Capra Species 0.000 description 3
- 241001495142 Helicobacter heilmannii Species 0.000 description 3
- 229920001213 Polysorbate 20 Polymers 0.000 description 3
- APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 3
- 229960003942 amphotericin b Drugs 0.000 description 3
- 239000011545 carbonate/bicarbonate buffer Substances 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 238000009630 liquid culture Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 3
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 229940107700 pyruvic acid Drugs 0.000 description 3
- 238000011002 quantification Methods 0.000 description 3
- 238000003753 real-time PCR Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 238000004879 turbidimetry Methods 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- 241000282326 Felis catus Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 101710116435 Outer membrane protein Proteins 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- 208000005718 Stomach Neoplasms Diseases 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 210000005056 cell body Anatomy 0.000 description 2
- 238000012767 chemiluminescent enzyme immunoassay Methods 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 208000023652 chronic gastritis Diseases 0.000 description 2
- 239000000084 colloidal system Substances 0.000 description 2
- 238000004737 colorimetric analysis Methods 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 208000000718 duodenal ulcer Diseases 0.000 description 2
- 239000012894 fetal calf serum Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 206010017758 gastric cancer Diseases 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 238000003119 immunoblot Methods 0.000 description 2
- 238000005305 interferometry Methods 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 210000002751 lymph Anatomy 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000012134 rapid urease test Methods 0.000 description 2
- 238000004062 sedimentation Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 201000011549 stomach cancer Diseases 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 239000013076 target substance Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 208000003950 B-cell lymphoma Diseases 0.000 description 1
- 241000589562 Brucella Species 0.000 description 1
- 208000014540 Functional gastrointestinal disease Diseases 0.000 description 1
- 241001026434 Helicobacter ailurogastricus Species 0.000 description 1
- 241001379776 Helicobacter baculiformis Species 0.000 description 1
- 241000990166 Helicobacter cetorum Species 0.000 description 1
- 241000590017 Helicobacter felis Species 0.000 description 1
- 241000590006 Helicobacter mustelae Species 0.000 description 1
- 108091006905 Human Serum Albumin Proteins 0.000 description 1
- 102000008100 Human Serum Albumin Human genes 0.000 description 1
- 206010021245 Idiopathic thrombocytopenic purpura Diseases 0.000 description 1
- 208000031671 Large B-Cell Diffuse Lymphoma Diseases 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 108010058846 Ovalbumin Proteins 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 108010003723 Single-Domain Antibodies Proteins 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 208000031981 Thrombocytopenic Idiopathic Purpura Diseases 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 210000001742 aqueous humor Anatomy 0.000 description 1
- 201000003710 autoimmune thrombocytopenic purpura Diseases 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010012818 diffuse large B-cell lymphoma Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 208000017215 gastric mucosa-associated lymphoid tissue lymphoma Diseases 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- KIGJWIPKAWAGCE-UHFFFAOYSA-L gun blue Chemical compound Cl.[Cu+2].O[Se](=O)=O.[O-]S([O-])(=O)=O KIGJWIPKAWAGCE-UHFFFAOYSA-L 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 210000003563 lymphoid tissue Anatomy 0.000 description 1
- 239000006249 magnetic particle Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000004848 nephelometry Methods 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 229940092253 ovalbumin Drugs 0.000 description 1
- 102000013415 peroxidase activity proteins Human genes 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 235000020030 perry Nutrition 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 210000004911 serous fluid Anatomy 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 208000018556 stomach disease Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000001138 tear Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56922—Campylobacter
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022009397 | 2022-01-25 | ||
| JP2022-009397 | 2022-01-25 | ||
| PCT/JP2023/002330 WO2023145789A1 (ja) | 2022-01-25 | 2023-01-25 | 全菌体を用いた、ヘリコバクター・スイス抗体の検出法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN118613722A true CN118613722A (zh) | 2024-09-06 |
Family
ID=87471511
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202380018734.XA Pending CN118613722A (zh) | 2022-01-25 | 2023-01-25 | 使用全菌体的检测猪螺杆菌抗体的方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250110123A1 (enrdf_load_stackoverflow) |
| EP (1) | EP4465044A4 (enrdf_load_stackoverflow) |
| JP (1) | JPWO2023145789A1 (enrdf_load_stackoverflow) |
| CN (1) | CN118613722A (enrdf_load_stackoverflow) |
| WO (1) | WO2023145789A1 (enrdf_load_stackoverflow) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4139840B4 (de) * | 1990-12-04 | 2005-06-02 | Quidel Corp., San Diego | Antigen-Zubereitung zum Nachweis von H. pylori |
| US20060193866A1 (en) * | 2003-04-22 | 2006-08-31 | Intercell Ag | H pylori antigens |
| JP2006284567A (ja) * | 2005-03-08 | 2006-10-19 | Pharma Foods International Co Ltd | ヘリコバクター・ピロリ感染の診断方法及び診断キット |
| US7939079B2 (en) * | 2006-11-14 | 2011-05-10 | Universiteit Gent | Helicobacter species and cultivation thereof |
| JP2016010331A (ja) | 2014-06-27 | 2016-01-21 | 学校法人北里研究所 | ヘリコバクター・スイス特異的配列、及び当該配列及び当該配列にコードされているタンパク質を標的とした診断方法 |
| JP6968113B2 (ja) | 2016-06-30 | 2021-11-17 | テンダイン ホールディングス，インコーポレイテッド | 人工心臓弁の経心尖送達装置 |
| WO2019225639A1 (ja) | 2018-05-23 | 2019-11-28 | 学校法人北里研究所 | ヘリコバクター・スイス感染の診断法 |
-
2023
- 2023-01-25 US US18/833,175 patent/US20250110123A1/en active Pending
- 2023-01-25 JP JP2023576957A patent/JPWO2023145789A1/ja active Pending
- 2023-01-25 EP EP23746999.4A patent/EP4465044A4/en active Pending
- 2023-01-25 WO PCT/JP2023/002330 patent/WO2023145789A1/ja active Application Filing
- 2023-01-25 CN CN202380018734.XA patent/CN118613722A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JPWO2023145789A1 (enrdf_load_stackoverflow) | 2023-08-03 |
| EP4465044A1 (en) | 2024-11-20 |
| WO2023145789A1 (ja) | 2023-08-03 |
| EP4465044A4 (en) | 2025-04-09 |
| US20250110123A1 (en) | 2025-04-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7105970B1 (ja) | ＳＡＲＳ－ＣｏＶ－２の免疫測定方法及び免疫測定キット | |
| JP7216948B1 (ja) | ＳＡＲＳ－ＣｏＶ－２の免疫測定方法及び免疫測定キット、並びにモノクローナル抗体又はその抗体断片 | |
| CN103380379B (zh) | 尿路感染的诊断方法 | |
| US20150192583A1 (en) | Hbv immunocomplexes for response prediction and therapy monitoring of chronic hbv patients | |
| US20220120737A1 (en) | Method for detecting sars-cov-2-specific serum human immunoglobulins | |
| JP2024178283A (ja) | 抗体コンジュゲート | |
| US20230333097A1 (en) | KIT FOR DETECTING ANTI-VINCULIN-IMMUNOGLOBULIN G (IgG) ANTIBODY | |
| JP7315968B2 (ja) | 生物学的試料中の遊離ａｉｍの免疫学的分析方法及び対象におけるｎａｓｈの検出方法 | |
| EP4465044A1 (en) | Method for detecting helicobacter suis antibody using whole bacterial cell | |
| EP4465043A1 (en) | Method for detecting helicobacter suis antibody using bacterial solubilizing fraction | |
| EP4467979A1 (en) | Method for detecting helicobacter suis antibody using bacterial outer membrane fraction | |
| US20230035402A1 (en) | Misfolded sod1 assay | |
| JP7523129B2 (ja) | ヘリコバクター・ピロリ菌株の同定方法、および同定用キット | |
| Kaur et al. | Pull Down Assay-Based Protein Analysis | |
| WO2004048976A1 (ja) | 黄色ブドウ球菌の検査方法 | |
| JP7693173B2 (ja) | マカダミアナッツアレルゲン特異的ＩｇＥを検出するための方法、マカダミアナッツアレルギー診断用体外診断薬、マカダミアナッツアレルゲン特異的ＩｇＥ検出用キット、およびマカダミアナッツアレルゲンの検出方法 | |
| JP2023547188A (ja) | 住血吸虫感染症の検出のためのタンパク質 | |
| CN114544958A (zh) | 一种检测SARS-CoV-2抗原的试剂盒、方法以及用途 | |
| WO2021240425A1 (en) | A method for rapid detection of antibodies against sars-cov-2 using recombinant nucleospike fusion protein | |
| CN115280146A (zh) | 包含人iv型胶原7s结构域的片段的测定方法以及用于该测定方法的试剂盒 | |
| CN114544947A (zh) | 一种检测SARS-CoV-2抗原的试剂盒、方法以及用途 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |